SUMMARY A canine in vitro right atrial preparation was developed to study the functional characteristics of subsidiary atrial pacemaker (SAP) activity and to compare them with those of sinoatrial node (SAN) activity. Extracellular bipolar electrodes were used to estimate the site of earliest activation and monitor spontaneous rate. Ligation of the SAN artery at the midportion of the sulcus terminalis suppressed SAN activity and usually (73.5%) elicited SAP activity in a well-defined region of the inferior atrium. SAP activity in this region required a "threshold" concentration of norepinephrine (10-8 l) in the Tyrode's perfusate. In response to all concentrations of norepinephrine tested, SAN activity attained a greater maximum spontaneous rate than SAP activity. Cholinergic stimulation with acetylcholine or eserine elicited a greater negative chronotropic response from SAP than SAN activity. Overdrive pacing suppressed SAP activity to a significantly greater extent than SAN activity. We conclude that this in vitro preparation can be useful for studying the pharmacology and electrophysiology of subsidiary atrial pacemakers that emerge after suppression of SAN activity. In contrast to SAN activity, SAP activity requires norepinephrine and is more sensitive than SAN activity to acetylcholine and overdrive pacing. Consequently, after loss of SAN function, autonomic modulation of SAP activity may result in atrial dysrhythmias and prolonged periods of overdrive suppression.
FOR THE PAST several years, this laboratory has been studying subsidiary atrial pacemaker (SAP) activity that emerges in the absence of sinoatrial node (SAN) activity. There is extensive evidence that after excision of the canine SAN in vivo, SAP activity emerges in regions along the sulcus terminalis or inferior right atrium." These subsidiary pacemakers are under autonomic control3' 4 and assume pacemaker function in the alert, conscious animal in which the SAN has been excised. 3'5 The existence of SAP activity is also supported by clinical6' 7 and other experimental studies. 8 1 Sealy and co-workers'0' 11 found that when the SAN of the dog was surgically excluded from the rest of the atrium, pacemaker sites in the lower right atrium assumed permanent dominance. Boineau and co-workers8 9 proposed that multiple pacemaker sites in the canine right atrium are part of a normal primary pacemaker complex.
Work from our laboratoryI has shown that after excision of the sulcus terminalis of the canine right atrium, including the SAN region, SAP activity assumes control of the heart. Subsidiary pacemakers are consistently located within a specific region of the inferior right atrium at its junction with the inferior vena cava, centi-meters from the SAN region. These pacemakers have been studied only with in vivo techniques. However, because of the limitations inherent in in vivo preparations, it is difficult to study the functional characteristics of these subsidiary pacemakers. Therefore, we have developed an in vitro right atrial preparation where SAP activity in this region of the right atrium can be studied under more controlled conditions. An in vitro preparation provides several advantages not shared by in vivo studies. For example, other regions of competitive subsidiary pacemaker activity, such as the coronary sinus, atrioventricular node and Bachmann's bundle, are excluded, autonomic reflex changes are not present, the influence of circulating catecholamines are eliminated, and the administration of drugs and the response to them can be quantitated more accurately. The purpose of this study was to develop an in vitro preparation for studying the functional characteristics of SAP activity and to compare these characteristics with those of SAN activity. Portions of this work have been reported in abstract form. 12
Methods Preparation
Seventy-four adult mongrel dogs of either sex that weighed 13-20 kg were anesthetized with sodium pentobarbital (30 mg/kg i.v.) and maintained by positivepressure respiration. A right thoracotomy was performed through the fourth intercostal space and the heart suspended by a pericardial cradle. Fifty-seven atria were selected for in vitro preparation based on the presence of a major branch of the right coronary artery leading to the SAN region, i.e., the SAN artery. The SAN artery was cannulated using the technique of James and Nadeau. 13 A 2-cm length of the right coronary artery was isolated near the origin of the SAN branch and ligatures were placed proximal and distal to this point. A fluid-filled cannula (PE 50) was intro-1378 duced into the proximal right coronary artery, advanced into the first 1 cm of the SAN artery and tied in place. The distribution of the cannulated artery to the SAN region was assessed by testing for injection bradycardial4 or by inspecting the distribution pattern after injecting 0.5 ml of indocyanine green dye.
After cannulation, the heart, with at least 2 cm of each vena cava, was quickly excised and immersed in room temperature Tyrode's solution equilibrated with 95% 02, 5% CO2. The composition of the Tyrode's solution used in all experiments was (in mM): NaCl 137, KCi 2.7, NaHCO3 11.9, NaH2PO4 0.33, CaCl2 1.8, MgCl2 1.05 and glucose 11, pH 7.4 + 0.02. Dissection was carried out according to the method described by Woods et al. ' 5 during perfusion of the preparation through the SAN artery with oxygenated room temperature Tyrode's solution at 2-4 ml/min by a roller pump. Ventricular tissue was removed by a cut made 1-2 cm below the atrioventricular groove (coronary sulcus). The right atrium was then opened by an incision along the tricuspid valve and up along the superior vena cava. The atrioventricular node, coronary sinus and all left atrial tissue up to the interatrial septum were removed. The remaining preparation consisted of the anterior free wall of the right atrium, including the atrial appendage, a portion of the interatrial septum and a small rim of right ventricular tissue containing the isolated right coronary artery. This preparation was transferred to a 200-ml tissue bath and pinned to the Sylgard floor, with the epicardial side up.
The perfusion cannula was switched to a second pump, which delivered oxygenated Tyrode's solution (Po2 550 ± 25.7 mm Hg) through a water-warmed thermostatic coil to yield a tissue temperature of 36 ± 1°C (YSI, model 47). Perfusion pressure was monitored by a transducer (Statham P23 Pb) connected to the perfusion line by a T-junction and displayed on a polygraph (Grass, model 7). Flow was maintained constant throughout each experiment at a rate (4.7 ± 0.1 ml/min) that yielded a perfusion pressure of 100 nmm Hg as determined at the start of each experiment. In addition to perfusion through the SAN artery, the atria were superfused with warmed Tyrode's solution at a rate of 10-12 ml/min. this study had a subsidiary SEA located more than 6 mm or four passive space constants17 from the ligation.
Pacemaker Characterization SAN and SAP activity were compared by their chronotropic responses to perfused neuromediators and to overdrive pacing. NE and acetylcholine were tested by perfusing varying concentrations of each for 30 seconds and 1 minute, respectively, while recording maximum changes in spontaneous rate. The concentration-response curves for acetylcholine were compared by the effective concentration that produced a half-maximum response (EC50). Time was allowed for complete recovery of spontaneous rate between test perfusions.
The response to overdrive pacing was determined by driving SAN and SAP activity at rates 100%, 150% and 200% above their control spontaneous rates for 0.5, 1 or 2 minutes. Stimulation was achieved by applying rectangular pulses, 2 msec in duration and 50% above threshold voltage to the inferior right atrium through bipolar pin electrodes coupled to a stimulator (Pulsar 4i, Frederick Haer). The amount of suppression after each period of overdrive pacing was measured directly from the polygraph traces of the caudal reference electrogram. Corrected recovery time (CRT) was obtained by subtracting the control cycle length from the duration of pacemaker suppression, as measured from the last driven beat to the first spontaneous beat.
Drugs
All solutions were freshly prepared before each experiment. Acetylcholine chloride (Sigma Chemical Co.) was prepared from cold stock solutions. All NE solutions (levophed bitartrate, Breon) were prepared in Tyrode's solution containing 6 x 10-5 M ascorbic acid to minimize oxidation. Other drugs used in this study were methoxamine hydrochloride (Vasoxyl, Burroughs Wellcome), phentolamine (Regitine HCl, Ciba-Geigy), DL-propranolol hydrochloride (Sigma Chemical Co.) and eserine salicylate (Sigma Chemical Co.).
Statistics
Values are expressed as mean + SEM. Statistical comparisons were made using an unpaired t test. Differences were considered statistically significant at p < 0.05. Results
Control
Of the 74 dogs, 57 (77%) had a SAN artery originating from the right coronary artery and were therefore Figure 2 is an illustration of the location of the subsidiary SEAs found in all 36 preparations in which SAP activity was elicited after ligation of the SAN artery. Ligation of the SAN artery caudal to the control SEA always resulted in a gradual decline in spontaneous sinus activity. After a variable period, SAP activity emerged in these preparations to maintain atrial excitation. The extracellular mapping procedure was used to estimate the location of the subsidiary SEA. The site beneath the mobile electrode depolarized earlier than any of the reference sites and the activation sequence of the reference electrograms was retrograde compared with control ( fig. 1 ). Usually, conducted activity was recorded from regions of tissue above the ligation, probably because the superficial fibers were still viable as a result of the superfusion. In the presence of background NE (10-8M), suppression of SAN activity resulted in the appearance of SAP activity in 36 of the 49 preparations tested (73.5%). Of the remaining 13 preparations, six showed no evidence of SAP activity and seven developed pacemaker activity in which the SEA was less than four space constants from the ligation site. Consequently, these preparations were not used in this study. All 36 subsidiary SEAs were concentrated in a well-defined region of the inferior right atrium at its junction with the inferior vena cava (fig. 2) rhythm was determined. The procedure involved lowering the concentration of NE until SAP activity ceased or became irregular. The threshold was determined by increasing the concentration of NE in small steps until rhythmic activity resumed. This threshold concentration was 6.4 + 4.7 x 10-9 M. In 85% of the SAP preparations, the background level of NE used (10-8 M) was suprathreshold and therefore sufficient to sustain SAP activity. In the remaining 15%, SAP activity required NE concentrations greater than 5 x 10-8 M.
Adrenergic Effects Figure 4 shows the chronotropic response of SAN and SAP activities to concentrations of NE ranging from 5 x 10-8 to 5 x 10-6 M. Under control conditions, with constant background NE (10-8 M), SAP activity had a significantly lower spontaneous rate than sinus activity. When the preparations were exposed for 30 seconds to increasing concentrations of NE of 10-7 M or less, the maximum spontaneous rate of both SAN and SAP activity increased in a parallel fashion. However, at concentrations greater than 10-7 M, there was a significant difference in maximum spontaneous rate, resulting from a sharp increase in SAN activity. During these higher levels of adrenergic stimulation, there were small transient shifts in activation sequence, associated with abrupt increases in spontaneous rate contrast, the same concentrations of NE produced significantly smaller increases in SAP spontaneous rate and no detectable shifts in activation sequence. The effect of a-adrenergic stimulation was also tested by perfusing methoxamine for 1 minute while recording spontaneous rate. At 10-A M, methoxamine increased SAN activity slightly, by 3.0 + 2.5 beats/ min (n = 5; p > 0.20) but increased SAP activity significantly, by 5.3 ± 0.6 beats/min (n = 3; p < 0.02). At 10-4 M, methoxamine decreased both SAN and SAP activity by 11.7 ± 0.9 (n = 3) and 15.5 + 1.7 beats/min (n = 4), respectively (p < 0.01). Both the negative and positive chronotropic effects of methoxamine were blocked by phentolamine (5 x 10 -7 M), which by itself had no effect on spontaneous rate of SAN or SAP activities.
Cholinergic Effects Figure 5 shows the maximum chronotropic responses of SAN and SAP activity to concentrations of acetylcholine ranging from 10 8 lM to 7.5 x 10-6 M.
The curve describing the response of SAP activity is shifted far to the left, indicating that SAP activity is more sensitive to acetylcholine than to SAN activity. periods (0.5, 1 and 2 minutes) at three frequencies of pacing (100%, 150% and 200%) above control rate. The magnitude of suppressiorn of SAN and SAP activity was a function of both the magnitude and duration of the overdrive period. However, the SAP relationship had a much greater positive slope. Furthermore, at each magnitude of overdrive tested, the CRT for SAP activity was significantly greater than that for SAN activity for each pacing duration (p < 0.005). Suppression of SAP activity was measured in seconds, compared with milliseconds for SAN activity.
Discussion We have developed an in vitro model for studying SAP activity that emerges after suppression of SAN activity. Experiments using this preparation have found that (1) A well-defined region of SAP activity is located at the junction of the inferior right atrium with the inferior vena cava. (2) Unlike SAN activity, this SAP activity is dependent on background ,3-adrenergic stimulation. (3) In response to NE, SAN activity attains a significantly greater maximum spontaneous rate than SAP activity. (4) SAP activity is more sensitive than SAN activity to cholinergic stimulation, and (5) SAP activ-ity is overdrive-suppressed to a significantly greater extent than SAN activity.
Under control spontaneous rhythm, the SEA was consistently found within the SAN region, i.e., at the junction of the superior vena cava and the right atrial appendage. This pacemaker activity remained stable for several hours, as long as perfusion through its nutritive vasculature (the SAN artery) was maintained. This confirms the findings of Woods et al.' and Musgrave"6 in their in vitro studies of the canine sinus node.
With the mapping procedure used here, we found control SAN activity to be at a single site at any given time. This is in agreement with previous reports2 20. 21 but not consistent with recent reports of a multicentric atrial pacemaker complex.8 9 Difference between our results and those of Boineau et al. 8' I may be attributed to the different mapping procedures or the preparations used. However, the present study was not designed to determine the functional organization of sinus node pacemakers. Our experiments were more concerned with characterizing the functional responses of SAN pacemaker activity. The mapping procedure was used primarily to approximate the location of SAN pacemaker activity and monitor shifts in activation sequence before and after ligation of the SAN artery. With the administration of high concentrations of neuromediators we often monitored small transient shifts in SAN pacemaker activity. However, at no time did these interventions shift sinus pacemaker activity to the region of the inferior right atrium, found in this study to contain SAP activity.
By ligating the SAN artery at the midportion of the sulcus terminalis, we selectively interrupted flow to the SAN region and thereby suppressed SAN activity. As sinus pacemaker activity decreased to lower rates, SAP activity usually (73.5%) emerged to maintain atrial excitation. The Moreover, the site of SAP activity in the present study was located at the junction of the inferior right atrium with the inferior vena cava, approximately 1 cm caudal to their most inferior point C of the pacemaker complex.8 Furthermore, in the present study, SAP activity was more sensitive to cholinergic stimulation, while pacemaker activity at point C was reported to be least sensitive to parasympathetic stimulation.8 In the present study, /3-receptor blockade with propranolol abolished SAP activity, while point C of the pacemaker complex was found least affected by /3 blockade.8 Finally, infusion of acetylcholine or NE concentrations that produced large changes in spontaneous cycle length, never shifted pacemaker activity from the SAN region to the SAP region described here. Apparently, the subsidiary pacemakers described in the present study differ in location and functional properties from those in the SAN or an atrial pacemaker complex. In addition, they emerge after suppression of primary pacemaker activity.
Unlike sinus node activity, SAP activity depended on a background level of /8-adrenergic stimulation.
With this in vitro preparation, we could quantitatively determine the threshold concentration of NE required to sustain subsidiary activity. When the level of NE fell below this level or when propranolol was added to the perfusate, SAP activity became irregular or quiescent. These experiments corrolate well with our previous in vivo findings that when SAP activity is elicited after excision of the SAN region, the administration of propranolol frequently shifts pacemaker dominance to the atrioventricular junctional region. 22 In response to NE, SAN activityattained a maximum spontaneous rate significantly greater than SAP activity. This agrees with in vivo experiments by Jones et al.,' who studied SAP activity in dogs, where most of the crista terminalis, including the SAN region, had been excised 3-4 months earlier. Maximal heart rates of the SAN (preoperative) in response to exercise, isoproterenol and stellate stimulation during anesthesia were significantly greater than the response of SAP activity. The SAP activity in these chronic animals was mapped and found within the same region of the inferior right atrium as the SAP activity found here. Although SAP activity requires background adrenergic stimulation to support atrial excitation, the chronotropic response to adrenergic stimulation is always less than that of the SAN. This may reflect the differential effects of adrenergic stimultion on SAP impulse conduction and automaticity, respectively.
Using this in vitro preparation, a direct comparison of chronotropic responses indicated that SAP activity is more sensitive than SAN activity to acetylcholine.
Based on the concentration-response curves, the EC50 value for SAN activity was about 21 times greater than that for SAP activity. In addition, the fact that eserine elicited a greater negative chronotropic response from SAP than from SAN activity also supports the conclusion that SAP activity is more sensitive to acetylcholine. In dogs in which the SAN region was surgically excised3 or destroyed by embolization23 several months earlier, SAP activity was hypersensitive to parasympathetic stimulation or atropine administration. Similar to the present experiments with acetylcholine, the recovery of SAP after vagal stimulation was also prolonged.
The present experiments demonstrate that the SAP region is within the distribution of the SAN artery. Therefore, infusions of parasympathomimetic agents (acetylcholine and eserine) into the SAN artery were distributed to the SAN region as well as to sites containing SAP activity. Moreover, these agents inhibited SAP activity more than SAN activity. This becomes particularly important in the interpretation of data ised to determine the functional hierarchy of SAP activity in the heart. Thus, Urthaler, James and co-workers13, 24 25 injected parasympathomimetic agents into the dog SAN artery in vivo to "selectively" inhibit sinus node activity. This resulted in atrioventricular junctional rhythms, which they concluded to be the second most automatic pacemaker site after failure of SAN activity. However, in the present experiments, more discrete suppression of SAN activity resulted in the appearance of SAP activity in regions of the inferior right atrium that are within the distribution of the SAN artery. These results are supported by the in situ experiments of Sealy et al. 10'" and Randall, Jones and co-workers, 1-3 who have also identified SAP activity in the inferior right atrium after surgical exclusion or excision of the SAN region, respectively. Taken together, the present results support the idea that after failure of the sinus node, the second most automatic pacemaker site is located within the right atrium.26
One important characteristic of SAP activity clearly 1385 VOL 67, No 6, JUNE 1983 distinguishing it from SAN activity was the signifi- 
